Literature DB >> 2574499

Tumor suppressor genes: the puzzle and the promise.

R Sager1.   

Abstract

Tumor suppressor genes are wild-type alleles of genes that play regulatory roles in cell proliferation, differentiation, and other cellular and systemic processes. It is their loss or inactivation that is oncogenic. The first evidence of tumor suppressor genes appeared in the early 1970s, but only within the past few years has a wealth of new information illuminated the central importance of these genes. Two or more different suppressor genes may be inactivated in the same tumors, and the same suppressors may be inactive in different tumor types (for example, lung, breast, and colon). The suppressor genes already identified are involved in cell cycle control, signal transduction, angiogenesis, and development, indicating that they contribute to a broad array of normal and tumor-related functions. It is proposed that tumor suppressor genes provide a vast untapped resource for anticancer therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574499     DOI: 10.1126/science.2574499

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  86 in total

1.  Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment.

Authors:  S W Lee; C Tomasetto; K Swisshelm; K Keyomarsi; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 2.  Gene therapy in clinical medicine.

Authors:  S M Selkirk
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

Review 3.  TGF-beta: problems and prospects.

Authors:  M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-11

4.  Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4.

Authors:  Y Ning; J L Weber; A M Killary; D H Ledbetter; J R Smith; O M Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

5.  Isolation of mesenchymal stem cells from cryopreserved human umbilical cord blood.

Authors:  Myoung Woo Lee; Mal Sook Yang; Joon Seong Park; Hugh C Kim; Young Jin Kim; Jeongeun Choi
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

6.  A novel blocker-PCR method for detection of rare mutant alleles in the presence of an excess amount of normal DNA.

Authors:  T Seyama; T Ito; T Hayashi; T Mizuno; N Nakamura; M Akiyama
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

7.  Molecular cloning of lin-29, a heterochronic gene required for the differentiation of hypodermal cells and the cessation of molting in C.elegans.

Authors:  A Papp; A E Rougvie; V Ambros
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

8.  Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

Authors:  W E Mercer; M T Shields; D Lin; E Appella; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

9.  Molecular analysis of chromosome region 11p13 in patients with Drash syndrome.

Authors:  L Jadresic; R B Wadey; B Buckle; T M Barratt; C D Mitchell; J K Cowell
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

10.  Positive selection of candidate tumor-suppressor genes by subtractive hybridization.

Authors:  S W Lee; C Tomasetto; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.